Lakefront Biotherapeutics N.V.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Shows the company changed its name and how US investors can own shares through American Depositary Receipts.
Stocky reads Lakefront Biotherapeutics N.V.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Lakefront Biotherapeutics N.V.'s most recent tracked filing was a 424B3 on 8 May 2026: Company renamed to Lakefront Biotherapeutics, offers ADR shares.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.